4.7 Article

A novel polymorphism of the human CD40 receptor with enhanced function

Journal

BLOOD
Volume 112, Issue 5, Pages 1863-1871

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2008-02-138925

Keywords

-

Categories

Funding

  1. National Institutes of Health (NIH
  2. Bethesda, MD) [AI28847, AI49993, CA099997]
  3. Department of Veterans' Affairs
  4. NIH [AR052125, A1063274, T32 AI007533]
  5. Lupus Foundation of Minnesota (Bloomington, MN)

Ask authors/readers for more resources

CD40 signaling is critical for innate and adaptive immunity against pathogens, and the cytoplasmic domain of CD40 is highly conserved both within and between species. A novel missense single nucleotide polymorphism (SNP) in the cytoplasmic domain of CD40 at position 227 (P227A) was identified, which resides on a conserved ancestral haplotype highly enriched in persons of Mexican and South American descent. Functional studies indicated that signaling via human (h) CD40-P227A stably expressed in several B-cell lines led to increased phosphorylation of c-Jun, increased secretion of the pro-inflammatory cytokines interleukin (IL)-6 and TNF-alpha, and increased Ig production, compared with wild-type hCD40. Cooperation between hCD40-P227A signaling and B-cell receptor (BCR)- or Toll-like receptor 9 (TLR9)-mediated signaling was also enhanced, resulting in elevated and synergistic production of IL-6 and Ig. We have thus identified a novel genetic variant of hCD40 with a gain-of-function immune phenotype.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available